Suppression of LETM1 by siRNA inhibits cell proliferation and invasion of bladder cancer cells.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Oncology Report

• Publication date

  2017-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/or.2017.5959PMID 29048663
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016.

  2017cited by this paper
• Downregulation of human Wnt3 in gastric cancer suppresses cell proliferation and induces apoptosis

  2016cited by this paper
• Knockdown of TC-1 enhances radiosensitivity of non-small cell lung cancer via the Wnt/β-catenin pathway

  2016cited by this paper
• Knockdown of β-catenin by siRNA influences proliferation, apoptosis and invasion of the colon cancer cell line SW480.

  2016cited by this paper
• Bladder cancer

  2016cited by this paper
• MYC, Metabolism, and Cancer.

  2015cited by this paper
• Clinical implication of leucine zipper/EF hand-containing transmembrane-1 overexpression in the prognosis of triple-negative breast cancer.

  2015cited by this paper
• Cancer statistics, 2015

  2015cited by this paper
• The role of WNT signalling in urothelial cell carcinoma.

  2015cited by this paper
• LETM1 overexpression is correlated with the clinical features and survival outcome of breast cancer.

  2015cited by this paper
• Genetic Variants in the Wnt/β-Catenin Signaling Pathway as Indicators of Bladder Cancer Risk.

  2015cited by this paper
• Decade in review—bladder cancer: International progress: from cytology to genomics

  2014cited by this paper
• High Expression of Leucine Zipper-EF-Hand Containing Transmembrane Protein 1 Predicts Poor Prognosis in Head and Neck Squamous Cell Carcinoma

  2014cited by this paper
• LETM1‐dependent mitochondrial Ca2+ flux modulates cellular bioenergetics and proliferation

  2014cited by this paper
• LETM1 haploinsufficiency causes mitochondrial defects in cells from humans with Wolf-Hirschhorn syndrome: implications for dissecting the underlying pathomechanisms in this condition

  2014cited by this paper
• Biomarkers for detection and surveillance of bladder cancer.

  2013cited by this paper
• Association of LETM1 and MRPL36 contributes to the regulation of mitochondrial ATP production and necrotic cell death.

  2009cited by this paper
• Transcriptional regulation of the cyclin D1 gene at a glance

  2008cited by this paper
• Proliferation and migration mediated by Dkk-1/Wnt/beta-catenin cascade in a model of hepatocellular carcinoma cells.

  2007cited by this paper
• LETM1, deleted in Wolf-Hirschhorn syndrome is required for normal mitochondrial morphology and cellular viability.

  2007cited by this paper
• Systemic chemotherapy for patients with bladder cancer--current controversies and future directions.

  2004cited by this paper
• Estrogens and Progesterone Promote Persistent CCND1 Gene Activation during G1 by Inducing Transcriptional Derepression via c-Jun/c-Fos/Estrogen Receptor (Progesterone Receptor) Complex Assembly to a Distal Regulatory Element and Recruitment of Cyclin D1 to Its Own Gene Promoter

  2004cited by this paper
• LETM1, a novel gene encoding a putative EF-hand Ca(2+)-binding protein, flanks the Wolf-Hirschhorn syndrome (WHS) critical region and is deleted in most WHS patients.

  1999cited by this paper
• LETM 1 haploinsufficiency causes mitochondrial defects in cells from humans with

  year unknowncited by this paper

• Mitochondria–ER crosstalk via MAMS: Bridging cellular homeostasis and cancer progression

  2026cites this paper
• Elevated levels of Letm1 drives mitochondrial dysfunction and cardiomyocyte stress-mediated apoptosis in cultured cardiomyocytes

  2025cites this paper
• The duality of GSK-3β in urinary bladder cancer: Tumor suppressor and promoter roles through multiple signaling pathways.

  2025cites this paper
• LETM1 and Mitochondrial Calcium Homeostasis: A Controversial but Critical Role in Cellular Function and Disease

  2025cites this paper
• The interplay between non­coding RNAs and Wnt/ ­catenin β signaling pathway in urinary tract cancers: from tumorigenesis to metastasis

  2022cites this paper
• Mitochondrial protein LETM1 and its-mediated CTMP are potential therapeutic targets for endometrial cancer

  2022cites this paper
• (Nano)platforms in bladder cancer therapy: Challenges and opportunities

  2022cites this paper
• The interplay between non-coding RNAs and Wnt/ß-catenin signaling pathway in urinary tract cancers: from tumorigenesis to metastasis

  2022cites this paper
• Centromere protein U enhances the progression of bladder cancer by promoting mitochondrial ribosomal protein s28 expression

  2021cites this paper
• Mitochondrial calcium exchange in physiology and disease.

  2021cites this paper
• LETM1 Knockdown Promotes Autophagy and Apoptosis Through AMP-Activated Protein Kinase Phosphorylation-Mediated Beclin-1/Bcl-2 Complex Dissociation in Hepatocellular Carcinoma

  2021cites this paper
• Mitochondrial calcium : mechanisms of transport , regulation and 1 cellular functions [ Au : OK ? Or ‘ Mitochondrial calcium : 2 machineries , regulation and cellular functions ’ ? ]

  2021cites this paper
• LETM1: A Single Entity With Diverse Impact on Mitochondrial Metabolism and Cellular Signaling

  2021cites this paper
• The ER-mitochondria Ca2+ signaling in cancer progression: Fueling the monster.

  2021cites this paper
• Suppression of LETM1 inhibits the proliferation and stemness of colorectal cancer cells through reactive oxygen species–induced autophagy

  2020cites this paper
• Long non-coding RNA RHPN1-AS1 promotes tumorigenesis and metastasis of ovarian cancer by acting as a ceRNA against miR-596 and upregulating LETM1

  2020cites this paper
• Leucine Zipper-EF-Hand Containing Transmembrane Protein 1 Is a Potential Prognostic Biomarker and Promotes Cell Progression in Prostate Cancer

  2020cites this paper
• Natural genetic variation in Stim1 creates stroke in the spontaneously hypertensive rat

  2020cites this paper
• CMAR_A_236482 1649..1660

  2020cites this paper
• LETM1 Promotes Gastric Cancer Cell Proliferation, Migration, and Invasion via the PI3K/Akt Signaling Pathway

  2020cites this paper
• DDX11-AS1exacerbates bladder cancer progression by enhancing CDK6 expression via suppressing miR-499b-5p.

  2020cites this paper
• Structural Mechanisms of Store-Operated and Mitochondrial Calcium Regulation: Initiation Points for Drug Discovery

  2020cites this paper
• Molecular machinery regulating mitochondrial calcium levels: The nuts and bolts of mitochondrial calcium dynamics.

  2020cites this paper
• Wnt signalling pathway in bladder cancer.

  2020cites this paper
• Molecular Mechanisms of Leucine Zipper EF-Hand Containing Transmembrane Protein-1 Function in Health and Disease

  2019cites this paper
• Germ-line genetic variation in the immunoglobulin heavy chain creates stroke suceptibility in the spontaneously hypertensive rat.

  2019cites this paper
• MicroRNA-153 Decreases Tryptophan Catabolism and Inhibits Angiogenesis in Bladder Cancer by Targeting Indoleamine 2,3-Dioxygenase 1

  2019cites this paper
• LETM1 is a potential cancer stem-like cell marker and predicts poor prognosis in colorectal adenocarcinoma.

  2019cites this paper
• Clinicohistopathological implications of phosphoserine 9 glycogen synthase kinase-3β/ β-catenin in urinary bladder cancer patients

  2019cites this paper
• LETM1 is required for mitochondrial homeostasis and cellular viability

  2019cites this paper
• Ca2+-Binding Proteins of the EF-Hand Superfamily: Diagnostic and Prognostic Biomarkers and Novel Therapeutic Targets.

  2019cites this paper
• The machineries, regulation and cellular functions of mitochondrial calcium

  2018cites this paper
• Knockdown of LETM1 inhibits proliferation and metastasis of human renal cell carcinoma cells

  2018cites this paper
• Programmed cell death 4 overexpression enhances sensitivity to cisplatin via the JNK/c-Jun signaling pathway in bladder cancer.

  2018cites this paper